Parcharee Tivitmahaisoon

Parcharee Tivitmahaisoon has a strong background in medicinal chemistry and research. Parcharee currently works at RAPT Therapeutics as a Scientist I, where they started in January 2022. Prior to this role, they held positions as an Associate Scientist and Research Associate III at the same company. Parcharee also worked as an R&D Medicinal Chemist at FLX Bio, Inc. from November 2017 onwards.

Before joining RAPT Therapeutics and FLX Bio, Inc., Parcharee Tivitmahaisoon served as a Staff Scientist at Yumanity Therapeutics from December 2015 to November 2017.

From 2012 to 2015, they worked at H3 Biomedicine as a Research Associate, specializing in designing and synthesizing splicing modulators. Their contributions included route development and optimization, as well as scale-up of chiral intermediates and lead compounds. Parcharee Tivitmahaisoon was also involved in route optimization and design efforts that led to a patent as a co-inventor.

Earlier in their career, Parcharee Tivitmahaisoon held roles at Roche. Parcharee worked as a Senior Research Associate from September 2011 to November 2012, and as a Research Associate III from January 2007 to August 2011. Their responsibilities included synthesis route design, optimization, and molecular design for improving potency and pharmacokinetic properties. Parcharee actively contributed to patent work stream committees and was included on multiple patents. Additionally, they worked as a Research Associate II from April 2001 to December 2006.

Parcharee Tivitmahaisoon began their career as an Associate Chemist at Dupont-Merck, where they carried out research on the synthesis of corticotrophin-releasing hormone antagonists. Parcharee also worked as a summer research exchange student at Leiden University, where they focused on multi-gram synthesis for the total synthesis of labeled ubiquinones and plastoquinones.

Overall, Parcharee Tivitmahaisoon's work experience showcases their expertise in medicinal chemistry, research, and drug development across various organizations in the biotechnology and pharmaceutical industries.

Parcharee Tivitmahaisoon completed a Bachelor of Science in Chemistry from Bucknell University between 1992 and 1996. Parcharee then pursued further education and obtained a Master of Science degree in Chemistry from UC Irvine between 1998 and 2001.